Data / Form D filings / IMMUNIC, INC.
IMMUNIC, INC.: Form D filings
IMMUNIC, INC., a biotechnology company in New York, United States, filed 24 Form D notices with the SEC between 2009 and 2026. The latest, on March 4, 2026, reports $200 million sold of a $200 million offering to 43 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1200 AVENUE OF THE AMERICAS SUITE 200, New York, United States, 10036
- Phone
- (332) 255-9818
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1280776
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | New notice | $200,000,000 | $200,000,000 | 43 | Feb 17, 2026 | sec.gov | |
| Jan 19, 2024 | New notice | $240,000,000 | $80,000,016 | $159,999,984 | 19 | Jan 4, 2024 | sec.gov |
| Oct 18, 2022 | New notice | $60,000,002 | $60,000,002 | 14 | Oct 10, 2022 | sec.gov | |
| Mar 7, 2014 | Amendment | $13,928,129 | $13,928,129 | 37 | Jan 24, 2014 | sec.gov | |
| Feb 4, 2014 | New notice | $12,000,000 | $12,000,000 | 20 | Jan 24, 2014 | sec.gov | |
| Jan 31, 2014 | Amendment | $31,979,470 | $31,979,470 | 62 | Feb 28, 2013 | sec.gov | |
| Jun 24, 2013 | Amendment | $22,540,339 | $22,540,339 | 15 | Feb 28, 2013 | sec.gov | |
| Mar 14, 2013 | New notice | $14,260,000 | $14,260,000 | 12 | Feb 28, 2013 | sec.gov | |
| Nov 7, 2012 | Amendment | $86,145,589 | $86,145,589 | 40 | Sep 25, 2012 | sec.gov | |
| Oct 9, 2012 | New notice | $76,145,589 | $76,145,589 | 11 | Sep 25, 2012 | sec.gov | |
| Jun 22, 2012 | New notice | Indefinite | $2,500,000 | 1 | May 14, 2012 | sec.gov | |
| Feb 17, 2012 | New notice | $1,500,000 | $929,831 | $570,169 | 7 | Feb 3, 2012 | sec.gov |
| Jun 23, 2011 | New notice | $56,860,223 | $22,617,179 | $34,243,044 | 51 | May 19, 2011 | sec.gov |
| Jun 22, 2011 | Amendment | $16,251,091 | $16,251,091 | 42 | Sep 25, 2009 | sec.gov | |
| Feb 7, 2011 | Amendment | Indefinite | $14,041,092 | 42 | Sep 25, 2009 | sec.gov | |
| Jan 4, 2011 | Amendment | Indefinite | $13,391,092 | 42 | Sep 25, 2009 | sec.gov | |
| Oct 15, 2010 | Amendment | Indefinite | $12,488,333 | 42 | Sep 25, 2009 | sec.gov | |
| Jul 1, 2010 | Amendment | Indefinite | $9,488,333 | 41 | Sep 25, 2009 | sec.gov | |
| Jun 23, 2010 | Amendment | Indefinite | $9,158,947 | 41 | Sep 25, 2009 | sec.gov | |
| May 14, 2010 | Amendment | Indefinite | $7,245,069 | 41 | Sep 25, 2009 | sec.gov | |
| Mar 18, 2010 | Amendment | Indefinite | $5,907,448 | 41 | Sep 25, 2009 | sec.gov | |
| Dec 10, 2009 | Amendment | $5,000,000 | $3,965,435 | $1,034,565 | 41 | Sep 25, 2009 | sec.gov |
| Oct 28, 2009 | Amendment | $5,000,000 | $3,736,409 | $1,263,591 | 34 | Sep 25, 2009 | sec.gov |
| Oct 7, 2009 | New notice | $5,000,000 | $1,158,255 | $3,841,745 | 32 | Sep 25, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DANIEL VITT | Executive Officer, Director | |
| SIMONA SKERJANEC | Director | |
| DUANE NASH | Director | |
| TAMAR HOWSON | Director | |
| JOERG NEERMAN | Director | |
| RICHARD RUDICK | Director | |
| ANDREAS MUEHLER | Executive Officer | |
| PATRICK WALSH | Executive Officer | |
| THORVALD NAGEL | Director | |
| HELLA KOHLHOF | Executive Officer | |
| GLENN WHALEY | Executive Officer | |
| INDERPAL SINGH | Executive Officer | |
| BARCLAY PHILLIPS | Director | |
| JASON TARDIO | Executive Officer |
Every Form D from the week of Mar 2, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IMMUNIC, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.